Contrasting Sonova (SONVY) & Its Competitors

Sonova (OTCMKTS: SONVY) is one of 46 publicly-traded companies in the “Electromedical equipment” industry, but how does it contrast to its rivals? We will compare Sonova to related businesses based on the strength of its risk, institutional ownership, dividends, valuation, analyst recommendations, earnings and profitability.

Valuation and Earnings

This table compares Sonova and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Sonova $2.43 billion $354.51 million 32.37
Sonova Competitors $1.11 billion $97.36 million -29.63

Sonova has higher revenue and earnings than its rivals. Sonova is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Dividends

Sonova pays an annual dividend of $0.27 per share and has a dividend yield of 0.8%. Sonova pays out 25.0% of its earnings in the form of a dividend. As a group, “Electromedical equipment” companies pay a dividend yield of 1.5% and pay out 37.6% of their earnings in the form of a dividend.

Profitability

This table compares Sonova and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sonova N/A N/A N/A
Sonova Competitors -169.18% -79.00% -19.73%

Insider and Institutional Ownership

0.2% of Sonova shares are owned by institutional investors. Comparatively, 41.7% of shares of all “Electromedical equipment” companies are owned by institutional investors. 20.5% of shares of all “Electromedical equipment” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Sonova and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonova 0 0 0 0 N/A
Sonova Competitors 154 469 1004 35 2.55

As a group, “Electromedical equipment” companies have a potential upside of 12.68%. Given Sonova’s rivals higher probable upside, analysts plainly believe Sonova has less favorable growth aspects than its rivals.

Summary

Sonova beats its rivals on 7 of the 11 factors compared.

Sonova Company Profile

Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand name; and professional audiological services under the Connect Hearing brand name. Sonova Holding offers its products through a sales and distribution network, which comprise approximately 50 Sonova-owned wholesale companies and 100 independent distributors; and AudioNova retail network of approximately 3,300 locations in 12 markets. It operates in the Americas, Europe, the Middle East, Africa, and the Asia/Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply